Vatalanib in Treating Patients With Recurrent or Progressive Meningioma

Summary

RATIONALE: Vatalanib may stop the growth of tumor cells by blocking blood flow to the tumor and by blocking some of the enzymes needed for cell growth. PURPOSE: This phase II trial is studying how well vatalanib works in treating patients with recurrent or progressive meningioma.

Timeline

Start

2006-05

Primary completion

2010-11

Completion

2013-07

Drugs

Indications